These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 8386236)

  • 1. In vitro and in vivo pharmacological characterization of N6-cyclopentyl-9-methyladenine (N-0840): a selective, orally active A1 adenosine receptor antagonist.
    Barrett RJ; May JM; Martin PL; Miller JR
    J Pharmacol Exp Ther; 1993 Apr; 265(1):227-36. PubMed ID: 8386236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of 8-(N-methylisopropyl)amino-N6-(5'-endohydroxy- endonorbornyl)-9-methyladenine (WRC-0571), a highly potent and selective, non-xanthine antagonist of A1 adenosine receptors.
    Martin PL; Wysocki RJ; Barrett RJ; May JM; Linden J
    J Pharmacol Exp Ther; 1996 Feb; 276(2):490-9. PubMed ID: 8632314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (+-)-N6-endonorbornan-2-yl-9-methyladenine (N-0861) and its enantiomers: selective antagonists of A1-adenosine receptors in guinea pig isolated atria.
    Martin PL; Potts AA; Sykes AM; McKenna DG
    J Pharmacol Exp Ther; 1993 Apr; 265(1):201-6. PubMed ID: 8474007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2-Phenylethoxy-9-methyladenine: an adenosine receptor antagonist that discriminates between A2 adenosine receptors in the aorta and the coronary vessels from the guinea pig.
    Martin PL; Ueeda M; Olsson RA
    J Pharmacol Exp Ther; 1993 Apr; 265(1):248-53. PubMed ID: 8474010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A1 and A2 adenosine receptor modulation of contractility in the cauda epididymis of the guinea-pig.
    Haynes JM; Alexander SP; Hill SJ
    Br J Pharmacol; 1998 Oct; 125(3):570-6. PubMed ID: 9806342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1,3-Dipropyl-8-[2-(5,6-epoxy)norbornyl]xanthine, a potent, specific and selective A1 adenosine receptor antagonist in the guinea pig heart and brain and in DDT1MF-2 cells.
    Belardinelli L; Shryock JC; Zhang Y; Scammells PJ; Olsson R; Dennis D; Milner P; Pfister J; Baker SP
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1167-76. PubMed ID: 8531078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cardiac effects of a novel A1-adenosine receptor agonist in guinea pig isolated heart.
    Belardinelli L; Lu J; Dennis D; Martens J; Shryock JC
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1371-82. PubMed ID: 7996449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The non-xanthine heterocyclic compound SCH 58261 is a new potent and selective A2a adenosine receptor antagonist.
    Zocchi C; Ongini E; Conti A; Monopoli A; Negretti A; Baraldi PG; Dionisotti S
    J Pharmacol Exp Ther; 1996 Feb; 276(2):398-404. PubMed ID: 8632302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A1 adenosine receptor modulation of electrically-evoked contractions in the bisected vas deferens and cauda epididymis of the guinea-pig.
    Haynes JM; Alexander SP; Hill SJ
    Br J Pharmacol; 1998 Jul; 124(5):964-70. PubMed ID: 9692782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel irreversible antagonist of the A1-adenosine receptor.
    Srinivas M; Shryock JC; Scammells PJ; Ruble J; Baker SP; Belardinelli L
    Mol Pharmacol; 1996 Jul; 50(1):196-205. PubMed ID: 8700113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CGS 21680C, an A2 selective adenosine receptor agonist with preferential hypotensive activity.
    Hutchison AJ; Webb RL; Oei HH; Ghai GR; Zimmerman MB; Williams M
    J Pharmacol Exp Ther; 1989 Oct; 251(1):47-55. PubMed ID: 2795469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of adenosine A2 receptors in bovine retinal membranes.
    Blazynski C; McIntosh H
    Exp Eye Res; 1993 May; 56(5):585-93. PubMed ID: 8500567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between binding affinities for brain A1 and A2 receptors of adenosine agonists and antagonists and their effects on heart rate and coronary vascular tone.
    Oei HH; Ghai GR; Zoganas HC; Stone GA; Zimmerman MB; Field FP; Williams M
    J Pharmacol Exp Ther; 1988 Dec; 247(3):882-8. PubMed ID: 2849674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of N-0861, (+-)-N6-endonorbornan-2-yl-9-methyladenine, as an A1 subtype-selective adenosine receptor antagonist in the guinea pig isolated heart.
    Shryock JC; Travagli HC; Belardinelli L
    J Pharmacol Exp Ther; 1992 Mar; 260(3):1292-9. PubMed ID: 1545393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological characterization of a simple behavioral response mediated selectively by central adenosine A1 receptors, using in vivo and in vitro techniques.
    Marston HM; Finlayson K; Maemoto T; Olverman HJ; Akahane A; Sharkey J; Butcher SP
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1023-30. PubMed ID: 9618404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The in vitro and in vivo pharmacological activity of Boiga dendrophila (mangrove catsnake) venom.
    Lumsden NG; Fry BG; Ventura S; Kini RM; Hodgson WC
    Auton Autacoid Pharmacol; 2004 Oct; 24(4):107-13. PubMed ID: 15595930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation of the hypothalamo-pituitary-adrenal axis in the rat by three selective type-4 phosphodiesterase inhibitors: in vitro and in vivo studies.
    Kumari M; Cover PO; Poyser RH; Buckingham JC
    Br J Pharmacol; 1997 Jun; 121(3):459-68. PubMed ID: 9179387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-0861 selectively antagonizes adenosine A1 receptors in vivo.
    Barrett RJ; Droppleman DA; Wright KF
    Eur J Pharmacol; 1992 May; 216(1):9-16. PubMed ID: 1526257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of pharmacological sensitivity to adenosine analogs in embryonic chick heart: role of A1 adenosine receptors and adenylyl cyclase inhibition.
    Blair TA; Parenti M; Murray TF
    Mol Pharmacol; 1989 May; 35(5):661-70. PubMed ID: 2498636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional and biochemical evidence for diazepam as a cyclic nucleotide phosphodiesterase type 4 inhibitor.
    Collado MC; Beleta J; Martinez E; Miralpeix M; Domènech T; Palacios JM; Hernández J
    Br J Pharmacol; 1998 Mar; 123(6):1047-54. PubMed ID: 9559885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.